SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001683168-18-000943
Filing Date
2018-04-06
Accepted
2018-04-06 13:39:40
Documents
59
Period of Report
2017-11-30

Document Format Files

Seq Description Document Type Size
1 ANNUAL REPORT gala_10k-113017.htm 10-K 596883
2 CERTIFICATION gala_10k-ex3101.htm EX-31.1 8494
3 CERTIFICATION gala_10k-ex3201.htm EX-32.1 4048
  Complete submission text file 0001683168-18-000943.txt   2988177

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE FILE glag-20171130.xml EX-101.INS 456712
5 XBRL SCHEMA FILE glag-20171130.xsd EX-101.SCH 39356
6 XBRL CALCULATION FILE glag-20171130_cal.xml EX-101.CAL 49411
7 XBRL DEFINITION FILE glag-20171130_def.xml EX-101.DEF 99834
8 XBRL LABEL FILE glag-20171130_lab.xml EX-101.LAB 257943
9 XBRL PRESENTATION FILE glag-20171130_pre.xml EX-101.PRE 204239
Mailing Address 18881 VON KARMAN AVE. SUITE 1440 IRVINE CA 92612
Business Address 18881 VON KARMAN AVE. SUITE 1440 IRVINE CA 92612 949-851-9261
Gala Pharmaceuticals Inc. (Filer) CIK: 0001513403 (see all company filings)

IRS No.: 421771014 | State of Incorp.: NV | Fiscal Year End: 1130
Type: 10-K | Act: 34 | File No.: 333-172744 | Film No.: 18742723
SIC: 2300 Apparel & Other Finishd Prods of Fabrics & Similar Matl